G01N 33/9453
Cardioregulators
Official title: {Cardioregulators, e.g. antihypotensives, antiarrhythmics}
G01N33/9453 (Cardioregulators) appears on 84 US grants and 49 published applications in this corpus.
Search patents in G01N- Granted patents
- 84
- Published applications
- 49
- Assignees
- 61
- Inventors
- 189
- Latest grant
- 5 Sep 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 3 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 4 | 0 |
| 1983 | 0 | 0 |
| 1984 | 4 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 7 | 0 |
| 1988 | 6 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 0 | 1 |
| 2003 | 0 | 4 |
| 2004 | 1 | 2 |
| 2005 | 1 | 2 |
| 2006 | 2 | 1 |
| 2007 | 2 | 2 |
| 2008 | 1 | 3 |
| 2009 | 2 | 0 |
| 2010 | 1 | 6 |
| 2011 | 4 | 4 |
| 2012 | 4 | 5 |
| 2013 | 2 | 4 |
| 2014 | 1 | 3 |
| 2015 | 1 | 3 |
| 2016 | 2 | 2 |
| 2017 | 0 | 1 |
| 2018 | 1 | 2 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Eplerenone for phenotyping of CYP3A5 enzyme activity in saliva samples5 Sep 2023US 11,747,352 B2Concordia University
- Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension5 Jun 2018US 9,989,543 B2Autotelic LLC
- RFamide-related peptides and methods thereof27 Dec 2016US 9,527,889 B2The Regents of the University of Michigan
- Methods for determining ligand binding to a target protein using a thermal shift assay27 Dec 2016US 9,528,996 B2Biotarget Engagement Interest Group AB
- Methods for determining ligand binding to a target protein using a thermal shift assay3 Mar 2015US 8,969,014 B2Evitraproteoma AB
- Anti-ouabain nanobody and application thereof24 Sep 2026US 2026/0286012 A1Nanjing University
- Immunochromatographic test strip for detecting digoxin and uses thereof25 Feb 2021US 2021/0055288 A1Beijing Diagreat Biotechnologies Co., Ltd.
- Eplerenone for Phenotyping of CYP3A5 Enzyme Activity in Saliva Samples26 Nov 2020US 2020/0371123 A1Concordia University
- Involvement of the bufodienolides in the diagnosis and treatment of post-traumatic stress disorder (ptsd)29 Nov 2018US 2018/0340947 A1
- Target modification for tracking and detection15 Nov 2018US 2018/0328919 A1Two Pore Guys, Inc.
Most cited
By later US patents
- Optical solid-phase biosensor based on polyionic layers labelled with fluorescent dyes94US 5,711,915 ABayer Aktiengesellschaft · 1998
- Reagents and methods for specific binding assays86US 6,153,442 ADade Behring Inc. · 2000
- Digoxigenin immunogens, antibodies, labeled conjugates, and related derivatives79US 4,469,797 AMiles Laboratories, Inc. · 1984
- Specific binding assays utilizing analyte-cytolysin conjugates44US 4,517,303 AE. I. Du Pont de Nemours and Company · 1985
- Heterogeneous immunoassay for digoxin using ouabain as a separation means34US 4,551,426 AE. I. Du Pont de Nemours and Company · 1985